Home
News
Topics
Sectors
Reports
Events
Clusters
Products
WEEKLY
FOCUS
ALPHA
Search
About Us
Sign in
Chemical Industry News, Data & Insights
About Us
Sign in
Home
News
Topics
Sectors
Reports
Events
Clusters
Products
WEEKLY
FOCUS
ALPHA
Products
WEEKLY
FOCUS
ALPHA
All news
(page 58)
26 February 2026
thyssenkrupp Automotive Body Solutions Joins IPAI for Smart Manufacturing Innovation
The company joins IPAI to integrate AI in manufacturing, enhancing robotics and expanding globally, with a focus on intelligent production and quality monitoring.
26 February 2026
Indaver to Acquire Medway Energy Centre from Low Carbon
Indaver plans to expand waste treatment in SE England, generating low-carbon electricity. The project aligns with their UK strategy and complements Low Carbon's development efforts.
26 February 2026
Grupa Azoty Introduces New Sulphur-Containing Fertilizer
The new product strengthens the fertilizer segment, supporting stable growth and competition in Europe while enhancing food security in Poland and the region.
26 February 2026
MOL Accuses JANAF of Legal Violations Over Russian Oil Transit
MOL demands JANAF allow unsanctioned Russian oil via sea, citing EU/US rules. Non-compliance may lead to legal action and claims for damages.
26 February 2026
PureCycle Technologies Q4 2025 Results and Update
Record production, revenue growth, expansion in Thailand and Belgium, and leadership changes. Gen-2 design shows cost efficiency. Financials stable with ongoing projects and debt management.
26 February 2026
TotalEnergies to Export 2 Mtpa LNG from Alaska Project for 20 Years
The Alaska LNG project, with a 20 Mtpa capacity, aims to supply Asia, enhancing energy security and transpacific ties. It has strong U.S. support and offers logistical advantages.
News type
Project Updates and Milestones
New Projects and Expansions
Mergers, Acquisitions, and Partnerships
Innovation and Product Development
Operational Changes and Investments
Sustainability and Environmental Initiatives
Financial Performance and Strategy
Executive Appointments and Governance Changes
Regulatory and Compliance Updates
Workforce and Corporate Social Responsibility (CSR)
Crisis and Risk Management
The right choices in the European chemical industry
Save time with
chemXplore Alpha
Learn more
26 February 2026
Asahi Kasei Acquires Aicuris for €780 Million
The acquisition enhances Asahi Kasei's pharmaceutical platform in severe infectious diseases, leveraging existing infrastructure for growth and expanding its treatment portfolio.
26 February 2026
FDA Approves Boehringer Ingelheim's HERNEXEOS for HER2-Mutant NSCLC
HERNEXEOS gains FDA approval for HER2-mutant NSCLC, showing a 76% response rate in trials. Further confirmation required for continued approval.
26 February 2026
Uniper's CCO Carsten Poppinga to Depart
Poppinga to join EnBW as Head of Trading post-cooling period. CEO Michael Lewis to cover CCO duties until a successor is named.
26 February 2026
Technip Energies Nominates John O’Higgins and Luc Rémont for Board Positions
Joseph Rinaldi to retire in 2026. John O’Higgins and Luc Rémont nominated as Board Observers, pending shareholder approval for Non-Executive Director roles.
26 February 2026
Johnson & Johnson Reports Positive Early Results for Pasritamig and Docetaxel in Prostate Cancer
Phase 1b study shows pasritamig and docetaxel combo is safe and effective in prostate cancer, with high PSA response rates, supporting Phase 3 trials.
26 February 2026
BASF Introduces Biomass Balance Autofroth Foam for North American Market
BMB Autofroth foam cuts carbon emissions by 18-20%, offers a drop-in solution for sustainability without process changes, and suits various applications.
26 February 2026
BASF Appoints Thomas Biegi for Communications and Government Relations
Thomas Biegi, with a strong background in pharma and biotech communications, will succeed Nina Schwab-Hautzinger in April 2026, reporting to Markus Kamieth.
26 February 2026
Lilly's Orforglipron Outperforms Semaglutide in Diabetes Trial
Orforglipron 36 mg reduced A1C by 2.2% and weight by 9.2%, surpassing semaglutide in a 52-week trial with 1,698 participants. Results published in The Lancet.
26 February 2026
Aramco Advances Gas Expansion with Jafurah and Tanajib Projects
Jafurah and Tanajib projects boost gas production, aiming for 80% capacity increase by 2030, supporting economic growth and energy diversification.
26 February 2026
Boehringer Ingelheim Licenses Immune Disease Program from Sitryx
Boehringer gains exclusive rights to Sitryx's preclinical program for autoimmune diseases, with potential payments over $500M and tiered royalties on future sales.
26 February 2026
Veolia Expands in India with Major Mumbai Water Projects
Secures 15-year contracts for Mumbai's largest water plants, enhancing water security and efficiency with advanced tech, aiming to double India's revenues by 2030.
26 February 2026
Veolia 2025 Results Overview
Strong 2025 results with growth in international markets, early ROCE target achievement, key acquisitions, increased dividend, and positive 2026 outlook.
26 February 2026
Veolia Secures £1bn UK Waste Management Contracts for 2025
11 new contracts with UK local authorities boost Veolia's municipal services by 35%, supporting decarbonisation and resource preservation.
26 February 2026
Eni Reports Strong 2025 Financial and Strategic Progress
Strong Q4 results with 35% net income growth. Major projects launched, production up 7%. LNG expansion, biofuels growth, and strategic partnerships enhance resilience and shareholder returns.
26 February 2026
Clariant Achieves Third Year of EBITDA Margin Growth
Q4 2025 sales rose 1% in local currencies. FY 2025 EBITDA margin up 180 basis points to 17.8%. Performance programs saved CHF 50M. 2026 sales expected flat; EBITDA margin around 18%.
26 February 2026
Covestro Meets 2025 Guidance Amid Challenges
Sales and EBITDA fell in 2025. Strategic moves and partnerships aim to boost growth. 2026 outlook: stable EBITDA, improved cash flow, and reduced emissions.
26 February 2026
Technip Energies 2025 Financial Results
Strong 2025 results with revenue and EBITDA growth, dividend increase, share buyback, and strategic acquisition. Positive outlook for 2026 with robust backlog and sustainability focus.
26 February 2026
2025 Results: Arkema Performance Summary
Strong cash flow and EBITDA, sales growth in key markets, successful capacity expansions, and sustainability progress. Dividend stable; 2026 targets slight EBITDA growth amid weak demand.
26 February 2026
EEW Advances Flue Gas Cleaning Modernization in Helmstedt
EEW invests in flue gas cleaning to meet strict emissions, enhance environmental performance, and ensure long-term site viability during ongoing operations in Helmstedt.
26 February 2026
RWE Expands Italy's Wind and Solar Capacity to 235 MW
RWE doubles its renewable projects in Italy, adding 123 MW in 2026. New wind and solar projects will power 190,000 homes, with more developments planned.
25 February 2026
ViiV Healthcare: Lotivibart Shows 94% Viral Suppression in Long-Acting HIV Treatment
Lotivibart, combined with CAB LA, maintained viral suppression in 94% of participants. Study progresses to test twice-yearly dosing. Well-tolerated with fewer adverse events in IV group.
25 February 2026
ViiV Healthcare Unveils Data on Twice-Yearly HIV Treatments
VH184 and VH499 show promise for twice-yearly HIV treatment, with improved resistance and tolerability, reducing the need for daily medication.
25 February 2026
Merck Animal Health's NUMELVI: FDA-Approved JAK Inhibitor for Canine Allergic Dermatitis
FDA approves NUMELVI for dogs 6+ months, a JAK inhibitor for allergic dermatitis, offering rapid itch relief and easy dosing. Available spring 2026.
25 February 2026
Merck Presents Phase 3 Trial Results for HIV-1 Treatment DOR/ISL at CROI 2026
DOR/ISL shows non-inferiority and similar safety to BIC/FTC/TAF in HIV-1 treatment-naïve adults and maintains suppression in those switching from other therapies.
← Previous
Next →
